(19)
(11) EP 2 798 077 A2

(12)

(88) Date of publication A3:
03.10.2013

(43) Date of publication:
05.11.2014 Bulletin 2014/45

(21) Application number: 12816419.1

(22) Date of filing: 28.12.2012
(51) International Patent Classification (IPC): 
C12Q 1/37(2006.01)
(86) International application number:
PCT/US2012/072086
(87) International publication number:
WO 2013/102088 (04.07.2013 Gazette 2013/27)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 31.12.2011 US 201161582339 P

(71) Applicants:
  • ALLERGAN, INC.
    Irvine, CA 92612 (US)
  • Wang, Joanne
    Irvine, California 92620 (US)
  • Dixit, Anuradha
    Irvine, California 92618 (US)
  • Abel, Kenton B.
    Irvine, 92612 (US)
  • Gupta, Swati
    San Diego, California 92130 (US)
  • Fernandez-Salas, Ester
    Fullerton, California 92831 (US)

(72) Inventors:
  • WANG, Joanne
    Irvine California 92620 (US)
  • DIXIT, Anuradha
    Irvine California 92618 (US)
  • ABEL, Kenton B.
    Irvine California 92612 (US)
  • GUPTA, Swati
    San Diego California 92130 (US)
  • FERNANDEZ-SALAS, Ester
    Fullerton California 92831 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) Highly Sensitive Cell-Based Assay to Detect the Presence of Active Botulinum Neurotoxin Serotype-A